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Abstract 
Tuberculosis caused by Mycobacterium tuberculosis, is one of the leading causes of death on a global scale. 
Multi-drug resistant and extremely drug resistant M. tuberculosis is a world-wide health threat. Pathogenic 
mycobacteria can survive because they are able to manipulate the host immune response in several ways. 
In a previous RNA sequencing study, several genes, including Clec4n was significantly upregulated in bone 
marrow-derived macrophages (BMDMs) infected with slow-growing mycobacteria (H37Rv and M. bovis 
BGC), compared to fast-growing mycobacteria (M. smegmatis) that were not able to survive. The 
experimental approach has been done as described in (Leisching et al., 2016a) and (Leisching et al., 2016b). 
In this study, the mouse gene Clec4n was studied to determine its  role in mycobacterial infection. The mouse 
Clec4n gene is translated into the Dectin-2 receptor that is able to recognize mycobacteria and initiate an 
immune response by binding to Mannose-capped lipoarabinomannan  (Man-LAM). BMDMs were infected 
with pathogenic (H37Rv) and non-pathogenic (M. smegmatis and M. bovis BCG) mycobacteria.  At a 12h and 
96h time point, RNA and protein was extracted for qPCR (molecular technique that monitors the 
amplification of a targeted DNA molecule) and western blots. To achieve a better understanding of the role 
that Dectin-2 plays during infection of pathogenic mycobacteria in mouse macrophages, the Dectin-2 
receptor was blocked with an anti-Dectin-2 antibody, to observe the effects on survival by Colony forming 
unit counts. In addition, the amount of release of key cytokines (TNFα and IL-10) by mouse macrophages 
was determined by Enzyme-linked immunosorbent assay (ELISA) (solid-phase enzyme immunoassay that 
detect the presence of a ligand in a liquid sample using antibodies directed against the protein to be 
measured).  
According to the qPCR results, the induced expression of Clec4n was only an early response, as decreased 
expression was determined at 96h post infection by M. bovis BCG and H37Rv. When the CFUs of 12h of 
infection was compared to the CFUs of 96h there was not a change in the survival or growth of the 
mycobacteria. Its results can indicate that Dectin-2 may influence the percentage uptake of H37Rv but not 
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the survival. The ELISA results showed that there was a significant increase in the production of TNFα , in the 
BMDMs infected with H37Rv and treated with the anti-dectin-2 antibody compared to the BMDMs infected 
with H37Rv but no antibody treatment, that suggests that binding of the antibody stimulated a higher 
production of TNFα. When the Dectin-2 antibody binds to the Dectin-2 receptor, mycobacteria binds to other 
receptors which initiate in a high production of TNF-α, that causes a high inflammatory response that leads 
to a lower survival of mycobacteria. To observe the response this effect has on the whole immune response, 
whole animal studies can be done. Gene silencing can be done with Dectin-2 to investigate the role it has on 
survival of pathogenic mycobacteria. Dectin-2 investigation can be done in human macrophages. 
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Uittreksel 
Tuberkulose, veroorsaak deur Mikobakterium Tuberkulose, is een van die grootste oorsake van dood 
wêreldwyd. Patogeniese mikobakterieë het die vermoë om te oorleef in die gasheer, omdat dit die 
immuunsisteem van die gasheer op verskeie maniere kan manipuleer. In ‘n vorige studie was ‘n RNA 
volgorde studie gedoen op verskeie gene, insluitende die muis Clec4n geen, wat beduidend opgereguleer 
was in in die beenmurg afgeleide Makrofae (BMAM) geÏnfekteer met mikobakterieë (M. tuberkulose en M. 
bovis BCG), wat die vermoë het om te oorleef in die makrofae in vergelyking met die BMAMs wat geÏnfekteer 
is met mikobakterieë (M. smegmatis) wat nie kan oorleef in die makrofae nie. Die eksperimentele 
benadering was gedoen soos beskryf in (Leisching et al., 2016a) en (Leisching et al., 2016b).  
 
In die studie word die muis Clec4n geen bestudeer om die vedere rol te bepaal wat dit speel tydens 
patogeniese mikobakterium infeksies.  Die muis Clec4n geen word getransleer in die Dectin-2 reseptor, wat 
mikobakterieë herken tydens infeksie, deur aan die Man-Lam van die mikobakterieë te bind en ‘n 
imuunrespons te inisieër. MBAMs was geÏnfekteer met H37Rv, M. bovis BCG en M. smegmatis. RNS en 
protëine was ge-isoleer na ‘n 12 - en 96 uur infeksie tyd punt vir kwalitatiewe polimerase kettingreaksie 
(PKR) (‘n molekulêre tegniek wat die amplifikasie van ‘n teiken DNS molekule monitor) en westerse blots. 
Om die rol wat Dectin-2 speel tydens infeksie van patogeniese mikobakterieë beter te verstaan, was die 
Dectin-2 reseptor geblok met n anti-dectin-2 teenliggaam, om die effek te observeer. Daar was geobserveer 
of die intersellulêre oorlewing van patogeniese mikobakterieë (H37Rv) verander wanneer die Dectin-2 
reseptor geblok word (deur te observeer of die kolonievormende eenhede verlaag), asook of die 
konsentrasie (pg per ml) van sitokienes (TNFα en IL-10) met behulp van ELISA (soliede-fase ensiem 
immunotoets wat die aanwesigheid van ‘n vloeistof monster opspoor deur teenliggame wat aan die protein 
kan bind, meet) verander (veral verlaag word), wanneer die dectin-2 reseptor geblok is.  
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Volgens die resultate van die kwalitatiewe PKR, speel Clec4n ‘n moontlike rol in die oorlewing van M. bovis 
BCG en H37Rv na ‘n 12 uur infeksie, weens die feit dat daar ‘n beduidende opregulasie van Clec4n in die 
BMAMs geÏnfekteer met M. bovis BCG en H37Rv in vergelyking met BMAMs geÏnfekteer met M. smegmatis  
was. Wanneer die KVE na 12 uur van infeksie vergelyk was met die KVE na 96 uur van infeksie, was daar geen 
verandering in die oorlewing of groei van die mikobaterieë. Die resultate dui dat Dectin-2 ‘n invloed het op 
die persentasie opname van H37Rv maar nie ‘n invloed op die oorlewing nie. In die ELISA resultate was daar 
gevind dat daar ‘n beduidende hoër produksie van TNFα sitokienes is in die BMAMs, geÏnfekteer met H37Rv 
en anti-dectin-2 teenliggaam behandeling was as in die BMAMs, geÏnfekteer met H37Rv en geen behandeling 
nie.  Dit dui daarop dat binding met die teenliggaam ‘n hoër produksie van TNFα sitokines gelewer het. Die 
Dectin-2 teenliggaam bind aan die Dectin-2 reseptor, as gevolg hiervan gaan bind die mikobakterieë aan 
ander reseptors wat die produksie van TNF-α sitokienes verhoog, wat ‘n hoë inflammatoriese reaksie 
veroorsaak en kan lei tot die verlaging van die orrlewing van mikobakterieë. Om die effek van die Dectin-2 
teenliggaam binding as ‘n geheel te observer in die immuunsisteem kan heel dier studies gedoen word. Geen 
uitdowing kan gedoen word op Dectin-2 om die rol daarvan in die oorlewing van patogeniese mikobakterieë 
te ondersoek. Die ondersoek van Dectin-2 kan gedoen word in mens makrofae.  
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CHAPTER 1: Literature review 
1.1 Background 
Tuberculosis (TB), caused by Mycobacterium tuberculosis, is a pandemic throughout the world. Many TB 
patients have been cured, but there are many that have multidrug resistant and extremely drug resistant TB 
that conventional drugs can not cure.  It is therefore crucial to look at alternative ways to combat the disease 
such as targeting the host immune response and developing host directed therapeutics. Pathogenic 
mycobacteria are able to avoid bactericidal host defences and prevent from being eliminated by an active 
immune response (Eht and Schnappinger, 2009).  In a RNA sequencing study several genes were identified 
to be significantly upregulated in bone marrow-derived macrophages (BMDMs) infected with mycobacteria 
(M. tuberculosis H37Rv, M. bovis BCG Bacillius Calmette Guérin) that are able to survive in the macrophages 
compared to mycobacteria (M. smegmatis) that are killed. In this study one of the identified genes, the 
mouse gene Clec4n was studied to determine its role in mycobacterial infection. The experimental approach 
has been done as described in (Leisching et al., 2016a) and (Leisching et al., 2016b). 
1.2 Infection by M. tuberculosis 
M. tuberculosis is spread through the air from an infected person to a healthy person. Once the bacterium 
has been inhaled, it enters the lungs and is taken up by alveolar macrophages and dendritic cells (Cooper, 
2009). Alveolar macrophages recognize specific pathogen-associated molecular patterns (PAMPs). M. 
Tuberculosis is taken up by alveolar macrophages though a process called phagocytosis. After the 
macrophages have been infected, they release pro-inflammatory cytokines that recruit other immune cells 
such as neutrophils, monocytes and dendritic cells to the lungs. Infected dendritic cells migrate to the lymph 
nodes where they initiate an adaptive immune response (Stamm et al., 2015). 
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In an adaptive immune response, granulomas are formed. Activated T lymphocytes move to the site of 
infection and start to form a granuloma. The cells form a necrotic central core that gives the mycobacteria 
nutritional supplements and limit the spread of  mycobacteria growth (Co et al., 2004). 
Infected macrophages secrete pro-inflammatory cytokines such as Tumor necrosis factor α (TNFα), 
Interferon γ (IFNγ), interleukin-12 and-23 and chemokines (Sasindran and Torrelles, 2011). The initial 
interaction between mycobacteria and its host, determines the pathway and the outcome of the infection. 
Specific host receptors are able to recognise mycobacteria and initiate an innate immune response however 
some receptors that recognise M. tuberculosis cause no pro-inflammatory response and lead to M. 
tuberculosis survival (Sasindran and Torrelles, 2011). 
Mycobacteria release antigens that are specific to it. These include lipomannan, lipoarabinomannan, and  
Mannose-capped lipoarabinomannan (ManLAM), lipoproteins, phthiocerol dimycocerosate (PDIM), and 
mycolic acids. These antigens are recognized by pattern recognition receptors. The main cell types involved 
in recognizing and intiating an immune response to M. tuberculosis, are macrophages and dendritic cells.  
(Stamm et al., 2015).  
1.2.1 Pattern Recognition Receptors 
The main surface receptors that recognize M. tuberculosis include Toll-like receptors, C-type lectin receptors 
and scavenger receptors. 
Toll-like receptors (TLR) that are found on the surface of macrophages are TLR 1, 2, 4 and 8. TLRs recognize 
a wide variety of structures from M. tuberculosis (Kawai and Akira, 2010). Different components of M. 
tuberculosis act with different TLRs. The TLRs that play a main role in recognizing M. tuberculosis are TLR 2, 
4, 8 and 9. TLR 2 can cause a strong pro-inflammatory response induced by the mycobacterium cell wall 
components such as lipoproteins (Harding and Boom, 2010).  
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Activation of TLRs leads to the activation of mitogen activated protein kinases (MAPKs), which initiate 
signalling cascades that cause the expression of the cytokine TNF α and several chemokines. It was found 
that this pathway could be exploited by pathogenic mycobacteria to promote survival of the mycobacteria 
within macrophages.  ManLAM from M. tuberculosis inhibits the activation of MAPK in human monocytes 
(Knutson et al., 1998).  
C-Type lectin receptors are plasma membrane molecules that are able to recognize carbohydrate moieties 
on the surface of pathogens. C-type lectin receptors that are able to recognize M. tuberculosis include 
mannose receptor (MR), DC-specific intercellular adhesion molecule-3 grabbing nonintegrin (DC-SIGN), 
Mincle, Dectin-1 and Dectin-2 (Killick et al., 2013). 
The mycobacterial cell envelope consists of high levels of mannose biomolecules that act as ligands for the 
mannose receptors on macrophages that contribute to M. tuberculosis pathogenesis. It has been found that 
the mannose receptor negatively regulates the macrophage pro-inflammatory response (Torrelles and 
Schlesinger, 2010). 
All mononuclear monocytes express complement receptors that regulate phagocytosis. M. tuberculosis have 
polysaccharides on their surface that bind to the Complement receptor 3 lectin domain, which moderates 
M. tuberculosis uptake by macrophages (Fenton et al., 2005).  
Complement receptor 3 (CR3) plays an important role in recognizing mycobacteria. For phagocytosis of 
mycobacteria though CR3, it requires the plasma membrane steroid cholesterol at the site of entry. 
Cholesterol increases the viscosity of the membrane that is in contact with the hydrophobic mycobacterial 
cell wall and thus increases the uptake by phagocytosis.  When CR3 is inhibited by antibody binding or the 
blocking of its lectin site, it leads to  reduction of mycobacterial uptake by phagocytosis (Gatfield and Pieters, 
2000). 
CR4 is highly abundant in cells that take up M. tuberculosis and is also known to play an important role in 
the early stages of M. tuberculosis infection (Hirsch et al., 1994).  
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1.2.2 Cytokines and Chemokines 
The immune response is regulated by polypeptides known as cytokines. The main cytokines involved are  
Tumor necrosis factor-α, Interleukin 12 (IL-12) and Interferons (Sasindran and Torrelles, 2011). 
Tumor necrosis factor-α (TNF-α) is an autocrine cytokine secreted from macrophages, dendritic cells and T- 
cells. TNF plays a role in granuloma formation and regulates some adhesion molecules that are crucial for 
granuloma formation. When TNF α is  uncontrolled, it leads to increased M. tuberculosis replication (Bean 
et al., 1999). 
Interleukin 12 (IL-12) is induced by macrophages and dendritic cells when they are activated though 
microbial TLR ligands. It plays a role in both innate and adaptive immune responses against M. tuberculosis. 
IL-12 activates the Janus Kinase Signal Transducer and Activator of Transcription (JAK-STAT) pathway that 
leads to the production of INF-γ, which in turn causes the production CD4 cells (Méndez-Samperio, 2008). 
The interferon family is divided into two types depending on its structure, function and  cell origin. Type 1 
include IFN-α and IFN-β and is produced through immune receptors through different cell types. Type 2 
includes IFN-γ and is produced when T lymphocyte and natural killer cells are stimulated. When macrophages 
are infected with M. tuberculosis,  IFN-α and IFN-β are produced, which stimulates the production of CD8+ 
and CD4+ T cells (Cho et al., 2002) and thus enhances the adaptive immune response.  
The type 1 interferon response can contribute to host susceptibility because the inflammatory response is 
overwhelming to the cell. IFN-γ is considered an important cytokine in the control of M. tuberculosis. It 
enhances the macrophages to produce pro-inflammatory cytokines, up-regulates surface expression of 
cytokines, chemokines, MHC 1 and MHC 2 molecules to allow macrophages to presents antigen to T- cells 
(Manca et al., 2001) 
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1.3 M. tuberculosis evades anti-mycobacterium mechanisms in the macrophage 
When a host is infected with a non-pathogenic mycobacterium such as M. smegmatis, the non-pathogenic 
mycobacterium is phagocytosed by macrophages (Figure 1.1). The phagosomes become acidified and fuse 
with lysosomes to become phagolysosomes. This environment is fatal to M. smegmatis and other non-
pathogenic mycobacteria, however pathogenic mycobacteria such as M. tuberculosis, have counter 
mechanisms that  enable them to prevent the fusion of phagosomes with lysosomes, thus enabling them to 
multiply and eventually be released to infect other macrophages and cause disease in the host (Bohsali et 
al., 2010). 
ManLAM has been found to block phagosome maturation. ManLAM blocks the PI3P (phosphatidylinositol 3 
phosphate)-dependant pathway that is involved in the transport of cargo between the trans-Golgi network 
and phagosomes, which is a transport step in phagosome maturation. A high Ca+2 concentration is needed 
in the cytosol of the macrophage for PI3P to bind to the phagosome prevented by ManLAM. ManLAM might 
also prevent  PI3P from interacting with phagosomes by binding to proteins containing domains that PI3P 
would normally bind to (Vergne et al., 2004). 
Pathogenic mycobacteria can survive because they are able to manipulate the host immune response in 
several ways (Figure 1.1). In a study (MCGARVEY et al., 2004) that monitored the gene expression of 
macrophage genes  infected with pathogenic mycobacteria (M. tuberculosis and M. avium) and non-
pathogenic mycobacteria (M. smegmatis), a difference in gene expression was observed between 
pathogenic and non-pathogenic mycobacteria. A Higher expression of genes that induce apoptosis was 
found in cells infected with M. tuberculosis and M. avium.  Cathepsin D and AP2M1, which are genes involved 
in lysosome acidification were suppressed in M. tuberculosis and M. avium in contrast to M. smegmatis 
(MCGARVEY et al., 2004) 
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The generation of reactive oxygen and nitrogen species also play a role in microbe degradation. Nitric oxide 
synthesis (iNOS) is a cytosolic enzyme that catalyses the conversion of L-arginine to L-cittruline and nitric 
oxide. Mycobacteria are able to prevent binding of iNOS to the phagosomes causing a reduction of nitric 
oxide production (MacMicking et al., 1997). The envasion of host killing is influenced by the receptor/s 
employed by mycobacteria upon entry into macrophages.  
 
 
 
Figure 1.1: There are different pathways of pathogenic and non-pathogenic mycobacteria when it 
infects the host. Pathogenic mycobacteria such as M. tuberculosis have found mechanisms to escape 
the fusion of the phagosomes with the lysosomes and in that way manages to survive. Image adapted 
from  (Koul et al., 2004). 
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1.4 Dendritic cell associated C-type lectin 2 Family 
Dectin-2 is part of the C-type lectin-like receptor family that play important roles in immunity and 
homeostasis. The Dectin-2 family, also known as dendritic cell-associated C-type lectin 2, includes Dectin-2, 
blood dendritic cell antigen 2, dendritic cell immunoactivating receptor, dendritic cell immunoreceptor, C-
type lectin superfamily 8 and macrophage inducible C-type lectin. These receptors consist of an extracellular 
conserved C-type lectin domain and they can mediate intracellular signalling either directly through integral 
signalling domains or indirectly by associating with signalling adaptor molecules. These receptors are able to 
recognize a variety of endogenous and exogenous ligands and function as pattern recognition receptors for 
different classes of pathogens that include fungi, bacteria and parasites that will lead to both an innate and 
adaptive immune response (Kerscher et al., 2013). 
The C-type lectin receptors can be found in either membrane bound or soluble forms. These receptors 
consist of at least one carbohydrate recognition domain, also known as a C-type lectin domain that is formed 
by disulphide bonds that are found between highly conserved cysteine residues. Many of the CTLRs are 
found to be multivalent. By being able to initiate intracellular signalling pathways, they are able to meditate 
cellular responses (Kerscher et al., 2013) 
The genes that encode the dendritic cell-associated C-type lectin-2 family, are grouped on the telomeric 
region of the natural killer gene cluster in mice in chromosome 6 and in human in chromosome 12. These 
CTLRs are type 2 transmembrane receptors that consist of a single extracellular conserved C-type lectin 
domain (Graham and Brown, 2009). 
1.4.1 Dectin-2  
Dectin-2 is expressed on a variety of myeloid cells. This includes tissues of macrophages, neutrophils and 
DCs. The Clec4n mouse gene, is translated into the Dectin-2 receptor. Dectin-2 is also expressed at low levels 
on peripheral blood monocytes although the expression can be highly upregulated during inflammation. 
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Human Dectin-2 has been found on monocytes and DCs and have also been expressed by lymphocytes. The 
human Dectin-2 gene, Clec6A is found on chromosome 12 and the mouse Dectin-2 gene is found on 
chromosome 6. (Taylor et al., 2005)   
Dectin-2 consists of an extracellular C-terminal C-type carbohydrate-recognition domain (CRD) that is linked 
to a transmembrane domain and a N-terminal cytoplastic domain (Figure 2.1). This receptor does not have 
any signalling motifs in its cytoplastic membrane.  Dectin-2 has a short cytoplasmic tail that binds with Fc 
receptor γ subunit (FcRγ), which consists of an immunotyrosine activation motif that interacts with Syk 
kinase, which leads to a secretion of several cytokines leading to a Th17 response. The binding of the Dectin-
2 receptor to FcRγ is mediated by a membrane-proximal part of its short cytoplasmic tail (Sato et al., 2006a). 
Dectin-2 plays a role as a pathogen recognition receptor that can recognize several pathogens.  The most 
general ligands for mouse Dectin-2 are α-mannas, M. tuberculosis, house dust mite, Fungi (Candidas), CD4+, 
CD25+ and T-cell ligand.   Signalling from Dectin-2 is mediated by Syk, PKCδ and CARD9-Bcl10-Malt1 (caspase 
recruitment domain-9-B-cell lymphoma translocation gene 1) pathway that leads to the production of a 
variety of cytokines and chemokines such as TNF-α, IL-2, IL-10, IL-23, IL-6 and IL-12. These cytokines leads to 
a Th1 and Th17 response (Sato et al., 2006a).  
Dectin-2 has a classical CTLD that contains a mannose binding motif that binds structures with a high 
mannose content. Dectin-2 is capable of recognizing a number of pathogens including M. tuberculosis (Sato 
et al., 2006a).  
1.5 Dectin-2 and its association with pathogens other than M.tuberculosis 
Previous studies have found that Dectin-2 is able to recognize  various pathogens. These include Candida 
albicans, Saccharomyces cerevisiae, Paracoccidioides brasiliensis, Histoplasma capsulatum, Aspergillus 
fumigatus, non-encapsulated Cryptococcus neoformans, Microsporum audouinii, Trichophyton rubrum, 
Schistosoma mansoni and house dust mite (Sato et al., 2006). Triggering of Dectin-2 induced a respiratory 
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burst (Gorjestani et al., 2011), and nucleotide-binding oligomerization domain-like receptor containing pyrin 
domains 3 (Nlrp3) inflammasome activation. The following includes more detail of how Dectin-2 plays a role 
in some of the above mentioned pathogens (Ritter et al., 2010). 
Dectin-2 is able to recognize C. albicans through β-glucan. During infection with C. albicans, Dectin-2 
regulates host inflammatory cytokine response and the development of adaptive immunity. Dectin-2 was 
found to preferably bind to hyphal rather than conidial components of C. albicans.  Mice without this 
receptor where found to have a higher susceptibility to this infection (Sato et al., 2006). 
The morbidity of S. mansoni, which is a human parasite,  occurs through the CD4+ T-cell mediated response 
to eggs that become trapped in the liver and intestinal tissue. Dectin-2 recognizes the parasitic worm, S. 
mansoni by its soluble schistosomal egg antigen (SEA). Dectin-2 stimulates an immune response through the 
Syk pathway. The Syk activity leads to  Nlrp3 inflammasome which alters adaptive immune responses (Ritter 
et al., 2010). 
House dust potently generates allergic inflammation. Extracts from the house dust mites, Dermatophagoids 
farina and Dermatophagoids pteronys and from the mold, Aspergillus fumigates stimulate the production of 
cysteinyl leukotrienes (cys-LTs) which are pro-inflammatory lipid mediators that cause bronchial smooth 
muscle constriction, vascular permeability and pulmonary inflammation in bronchial asthma. Transfection 
of each receptor in bone marrow mast cells revealed that only Dectin-2 mediates cys-LT production of these 
above named house dust mites and mold. Through the Dectin-2 mechanism, these allergens activate the 
immune cells to promote allergic inflammation (Barrett et al., 2009). 
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1.6 Dectin-2 and its association with M. tuberculosis 
M. tuberculosis contain a variety of immunomodulatory molecules on their cell walls. ManLAM is a major 
lipoglycan for M. tuberculosis. C-type lectin receptor Dectin-2 binds directly to Man-LAM. LAM consists of 
four components, which include mannosyl-phosphatidyl-myo-inositol anchor, a mannose backbone, 
arabinan domain and capping moieties (Misha et al., 2011). When Man-LAM binds to Dectin 2, a pro- and 
anti-inflammatory immune response is triggered in dendritic cells. Man-LAM can also cause a high T-cell 
mediated acquired immunity that leads to detrimental inflammation (Robinson et al., 2009). 
When Man-LAM is recognized, it causes an inflammatory response that includes cytokine production in 
dendritic cells. It induces the expression of inflammatory cytokines that include MIP-2, TNF-α and IL-6 
(Ariizumi et al., 2000). 
Figure 1.2: Dectin-2 contains a mannose binding motif that binds to mannose ligands. The FcRγ 
receptor is meditated by a membrane-proximal part of the Dectin-2 short cytoplasmic tail. 
Signalling from Dectin-2 is mediated by Syk, PKCδ and CARD9-Bcl10-Malt1 pathways. Cytokines 
that are expressed through this pathway leads to T cell differentiation.  Image adapted from (Plato 
et al., 2015). 
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Man-LAM also plays an immunosuppressive role. It induces the production of anti-inflammatory cytokine IL-
10 in bone marrow-derived dendritic cells (BMDCs). There was no release of IL-10 cytokines that was induced 
by Man-LAM in BMDCs form Clec4n-/- BMDC mutant mice. With infection with M. bovis BCG the production 
of IL-2 and IL-10 was very low in BMDCs from Clec4n-/- mutants. M. abscessus, which has no mannose cap, 
was also not able to cause an expression in these anti-inflammatory cytokines. The results suggested that 
Dectin-2 plays an important role in the production of IL-2 and IL-10 in response to mycobacterium (Yonekawa 
et al., 2014).  
Binding of Dectin-2 receptor both initiates pro- and anti-inflammatory responses. It is still unknown whether 
Dectin-2 receptor plays a protective or non-protective role towards Mycobacteria.  
1.7 Problem Statement and Motivation 
In a prior high-throughput RNA sequencing study, it was observed that the expression of several genes that 
included Clec4n (Dectin-2 gene) was significantly upregulated in mouse bone marrow-derived macrophages 
infected with slow-growing mycobacteria (H37Rv and M. bovis BGC) as compared to fast growing 
mycobacteria (M. smegmatis) that are not able to survive. Since conflicting reports about the pro- and anti- 
inflammatory responses induced by Dectin-2 exist, it remains unclear whether the engagement of Dectin-2 
by mycobacteria influences the survival of pathogenic mycobacteria.  
1.8 Hypothesis 
The induced gene expression of Clec4n yields an increase in Dectin-2 on the cell surface and influences the 
survival of slow-growing mycobacteria (H37Rv) and M. bovis BCG in mouse bone marrow-derived 
macrophages.  
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1.9 Aim 
To determine whether Dectin-2 influences the survival of slow-growing mycobacteria (H37Rv) in BMDMs.  
1.10 Objectives 
▪ To establish whether the gene expression of Dectin-2 in comparison with the different strains correspond 
with the results of the RNA-sequencing data.  
▪ To assess the expression of the Clec4n, TNF α and IL 10  gene at early (12h) and later (96h) time points in 
mouse bone-marrow-derived macrophages infected with slow-growing mycobacteria (H37Rv and M. 
bovis BCG) and fast-growing mycobacteria (M. smegmatis). 
▪ To determine if the Clec4n gene is translated into the Dectin-2 protein after expression when infected 
with mycobacteria, at a 12h and 96h time point.  
▪ To observe the difference in survival of the pathogenic mycobacteria (H37Rv) when blocking the Dectin-
2 receptor with a specific antibody. 
▪ To determine if blocking the Dectin-2 receptor affects the release of key cytokines (TNFα and IL-10)  
known to be induced by binding to Dectin-2. 
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CHAPTER 2: Materials and Methods 
In order to observe the gene expression of Dectin-2 during infection of mycobacteria (H37Rv and M.bovis 
BCG) that are able to survive in BMDMs and mycobacteria(M.smegmatis) that are not able to survive, the 
following needed to be done first.  
Mycobacteria (H37Rv, M.bovis BCG and M.smegmatis) were cultured in order for there to be stocks to infect 
the BMDMs with. Mycobacteria was titrated, so that the correct MOI (Multiplicity of Infection) could be 
calculated. BMDMs were cultured, differentiated and counted in order for the right MOI can be calculated. 
After infection RNA was extracted and converted to cDNA to be ready for qPCR. Protein was also extracted, 
and protein quantification was done to load the correct amount of protein for SDS-PAGE and western blot. 
The number of cells were estimated for 96 well plates  to calculate the right MOI. CFU counts were done 
and supernatant was collected for ELISAs. 
2.1 Mycobacteria stocks 
2.1.1 Culturing Mycobacteria 
The three mycobacterium strains being non-pathogenic M. smegmatis and attenuated M. bovis BCG and the 
pathogenic H37Rv strain, were obtained from the Division of Molecular Biology and Human Genetics, 
Stellenbosch University. The mycobacteria were grown in Middlebrook 7H9 (Difco, Becton Dickson, USA) 
medium supplemented with 10% oleic acid albumin-dextrose catalase (OADC, Becton Dickson, USA) 
enrichment medium and 0.5 % glycerol (Merck Millipore, Germany) excluding Tween 80. 
Slow growing mycobacteria which include H37Rv and BCG, were grown in the following way: A frozen stock 
vial of bacteria was thawed and syringed 10 times through a 25G needle (Becton Dickson, USA). The bacteria 
were inoculated into non-tween 80, Middlebrook 7H9 medium in two T25 flasks. The bacteria (0.5 ml) and 
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9.5 ml of Middlebrook 7H9 medium in each T25 flasks were placed in an incubator at 37 ֯ C. The culture was 
grown to an OD600 (Optical Density) of 0.3 absorbance taken in an MRC spectro UV-16 spectrophotometer.  
Each T25 flask was then split into five T25 flasks by adding 1 ml of starter culture and 9 ml of Middlebrook 
7H9 medium into each new T25 flask. They were then placed in an incubator at 37 ֯ C. The bacteria were 
grown to an OD600 of 0.4 absorbance. Each T25 flask was then split into two T25 flasks, which gave 20 T25 
flasks in total. The flasks were placed in an incubator at 37 ֯ C. The bacteria were grown to an OD600 of 0.4 
absorbance.  
The fast-growing mycobacteria included M. smegmatis and were grown in the following way: The OD600 was 
taken for the start culture. The initial culture started with 10 ml in a 100 ml Erlenmeyer flask. The culture 
started with an OD600 of 0.0025 absorbance. The bacteria were inoculated in Middlebrook 7H9 medium. The 
flask was incubated at 37˚C and shaker that showed visible swirling in a Lasec incubator. The OD600 was taken 
12h after incubation. The bacteria were then taken up to 50 ml each in four 500 ml Erlenmeyer flasks with 
an OD600 of 0.0025 absorbance. After 12h of incubation, the OD600 did not exceed 0.4 absorbance.  
2.1.2 Titration  
The cultures were combined into four 50 ml tubes and were given 10 min for the clumps to settle down. The 
top 45 ml of each tube was transferred into a new tube. The tubes were centrifuged at 1500 rpm for 5 min 
in an Eppendorf 5810 R Centrifuge and the supernatant was discarded. Each pellet was resuspended in 5 ml 
of 7H9 medium and mixed well by pipetting. Several 1ml tubes were filled with 1 ml of culture and stored at 
- 80˚C.  
Three vials of frozen bacteria stock (Three technical replicates) and a control added of Middlebrook 7H9 
medium were used for titration. The bacteria were pipetted though a 1 ml tip ten times and then syringed 
ten times though a 25G needle. The clumps could settle out in the following times: 1 min for M. smegmatis, 
30 Seconds for BCG and 10 min for H37Rv .The bacteria were added in a 15 ml tube which contained 4.250 
ml of Middlebrook 7H9 medium and 750 µl of bacteria. The bacteria were filtered through a 5.0 µm pore 
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size filter (Merck, Darmstadt, Germany), each one separately. Dilutions of each three were made from x10-1 
to x10-4 and 50 µl was plated out on a Middlebrook 7H11 (Difco, Becton Dickson, USA) agar split plate. The 
plates were incubated at 37  ̊C. After 3 days for M. smegmatis and 3 weeks for H37Rv and BCG the CFU was 
counted. An average was calculated between the 3 technical replicates which would be equal to  the number 
of bacteria per ml.  
2.2 Obtaining Murine Bone Marrow-Derived Macrophages 
Bone marrow-derived macrophages were obtained from femur bone marrow. The femurs were from four 
to six-week-old female C57BL/6 mice and the mice were obtained from the Animal Facility, Stellenbosch 
University. Ethics for primary cultures obtain from mice were approved with protocol number, SU-ACUD14-
00041. After the mouse femurs were obtained the bone marrow cells were extracted according to a protocol 
from Chantal De Chastellier (De Chastellier et al., 2009). 
The cells obtained were grown in RPMI- 1640 (containing L-glutamine and Na-bicarbonate, Lonza) which was 
supplemented with 10% L-cell conditioned medium (source CSF-1) and 10% heat-inactivated Foetal Bovine 
Serum (FBS, Biochrom, Germany) as growth medium. CSF-1 was required for the differentiation of precursor 
bone marrow cells to macrophages as well as for the maintenance of the cells. The murine bone marrow 
derived precursor cells were seeded in six well tissue culture plates (Cellstar, Sigma-Aldrich, USA) and placed 
in an incubator (37  ̊C, 5% CO2) for five days where they could adhere and differentiate into macrophages. 
The precursor cells were 1 x 105 cells per well (2 ml). After five days, undifferentiated cells were washed 
away, and clean medium was replaced daily until infection was done. After seven days, the macrophages 
were ready to be infected.  
2.3 Infection of Bone Marrow Derived Macrophages  
There were three biological replicates, which means that the infection process was done three times with 
BMDM that came from three different mice for the same time interval. There were two time intervals of 
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infection, namely a 12h and a 96h post-infection. These timepoints were chosen so that there was an early 
timepoint of infection (12h) and a late timepoint of infection (96h) involved in the study. The macrophages 
were infected with two non-pathogenic strains (M. smegmatis and M. bovis BCG), and a pathogenic strain 
(M.tubeculosis H37Rv). There also was an uninfected control, namely the macrophages that were not 
infected. M. smegmatis was excluded at the 96h time point of Infection.  
The Multiplicity of infection or MOI was 2, two bacilli for each macrophage. The syringe settle filtrate (SFF) 
method was used to break up and remove  mycobacterial clumps. After infection the plates were placed in 
an incubator (37  ̊C, 5% CO2). After 4h of infection, the cells were lysed, and the mycobacteria were plated 
out to observe the percentage uptake and MOI. The MOI was done at 4h because after 4h the maximum 
uptake of mycobacteria took place. After 4h the six well tissue culture plates were washed three times with 
phosphate buffered saline (PBS, Lonza, Walkersville, USA) and 0.1% Triton was added to each well. Dilutions 
of 1 x 10-1 – 1 x 10-4 for three technical replicates and of only the unfiltered bacteria were made to validate 
whether the MOI is 2. The dilutions were plated out on Middlebrook 7H11 agar plates (with 10% OADC 
enrichment medium and 0.5 % glycerol). The plates were placed in an incubator at 37  ̊C and the CFUs were 
counted. M. smegmatis was counted after three days while BCG and M. tuberculosis was counted after three 
weeks.  
2.4 RNA Extraction  
For RNA extraction, the RNeasy Plus Mini kit  Cat no. 74134 (Qiagen, Germany) was used. The RNA was 
extracted from the macrophages after infection of 12h and 96h according to  manufacturer’s instructions. 
To remove any DNA from the sample, a gDNA Eliminator column was included in the kit. The RNA samples 
were send to the Central Analytical Facility, Stellenbosch University. They used an Agilent 2100 Bioanalyzer 
to assess the quality and quantity of the RNA.  Only RNA with an integrity number (RIN) above 9.0 was used 
for quantitative Polymerase Chain Reaction experiments (qPCR). The RNA extraction was done in three 
biological replicates for each time interval. The samples were stored at – 80  ̊C.  
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2.5 Reverse Transcription  
The RNA was converted into cDNA with the QuantiTect Reverse transcription kit Cat no. 05311 (Qiagen, 
Germany) which included a gDNA wipe out. The volume of RNA that was used to be converted to cDNA was 
calculated depending on the concentration of each condition and biological replicate. The end concentration 
of the RNA was 0.5 ng per µl. Optimisation of cDNA calculations for 12h and 96h after infection is included 
in the appendix. The cDNA was made in the Applied Biosystems 96 well Thermal Cycler. The protocol was 
followed according to manufacture instructions of the kit. Dilutions were done by adding 80 µl RNase free 
water and 20 µl of cDNA for each sample. The samples were stored at – 20  ̊C.  
2.6 Quantitative Polymerase Chain Reaction and Analyses  
Quantitative Polymerase Chain reaction (qPCR) was done with the mouse gene, Clec4n. The qPCR was done 
in 96 well plates run on a LightCycler 96 (Roche, Germany).  
A Fast Start Essential DNA SYBR Green Master mix  Cat no. 06924204001 (Roche, Germany) was used for the 
gene, Clec4n with the primer, Clecf10 QuantiTect Primer Assay Cat no. QT00153832 (Qiagen, Netherlands) 
and Roche H2O that came with the Green Master Mix was added in volumes according to manufacturer’s 
instructions which resulted in a reaction volume of 20 µl. In the reaction volume 10 µl of the Master mix, 7µl 
H2O, 1 µl of the primer and 2 µl of the sample was included for one qPCR reaction.  
The reference genes employed were β-2-Microglobulin with the primer B2M QuantiTect Primer Assay Cat 
no. QT 01149547  (Qiagen, Netherlands) and Ubiquitin C with the primer UBC QuantiTect Primer Assay  Cat 
no. QT 00245189 (Qiagen, Netherlands). The amplification procedure included 45 cycles for 95  ̊C for 10 s 
each, followed by 60  ̊C for 10s and then 72  ̊C for 10 s.  
The experimental groups included M. smegmatis, BCG and H37Rv in the 12h timepoint and excluding M. 
smegmatis in the 96h time point with the uninfected as control.  There were three biological replicates and 
two technical replicates for each condition.  
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The samples of each time point were done on two different 96 well plates and a cDNA Calibrator was 
included in the plates. To be certain that no DNA contamination was included both for the conversion to 
cDNA and during qPCR, a non-reverse transcription control as well as a negative control was added 
respectively. The Roche lightCycler software version 1.1 program was used for qPCR analysis, were relative 
quantification was calculated, with B2M and UBC as reference genes, calibrator cDNA as run calibrator, and 
control (BMDMs with no infection) as study calibrator. Data visualization was normalized. The normalized 
ratio data was used for Prism. The relative expression which was generated by the software uses the delta 
delta Ct method. The qPCR was done according to the MIQE guidelines, which are included in the appendix. 
(Bustin et al., 2009). 
The qPCR results were analysed in GraphPad Prism software, where statistical analyses were applied. A one-
way ANOVA (and Nonparametric) test was done, with a Bonferroni (compare all pairs of columns) post-test. 
The significance level was Alpha = 0.05 (95%  confidence intervals). 
2.7 Protein Extraction 
After infection at 12h and 96h, protein was isolated. The wells were washed three times with Phosphate 
buffered saline (PBS) and then treated with RIPA buffer (Radioimmunoprecipitation assay buffer) which 
included 150 mM sodium chloride, 1.0% Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl 
sulfate and 50 mM Tris (pH 8). The proteins were syringed and filtered (Acrodisc LC 13 mm Syringe Filter 
with 0.2 µm PVDF Membrane, Sigma Aldrich, USA). The protein samples were stored at -80  C̊. 
2.8 Protein Quantification 
The protein quantification was done with the Bradford Assay. A standard curve was made by adding 900 µl 
of the quick start Bradford x 1 dye reagent and then a dilution of 10% Bovine Serum Albumin (BSA) cat no: 
HD14-4 (Qiagen, USA) for 0,10,20,40,60,80 and 100 µl and each dilution is filled up with dH2O to become 
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1ml. The 0 volume of BSA was used as a blank. The cuvettes were mixed by hand. The OD595 was taken off 
each dilution with a MRC spectro UV-16 spectrophotometer.  
The quick start Bradford x1 dye reagent cat no: 500-0205 (Bio-Rad, USA) of 900 µl was added in a cuvette 
with 95 µl of dH2O and 5 µl protein sample. The cuvettes were mixed by hand and the OD595 is taken of each 
sample with MRC spectro UV-16 spectrophotometer.  
The calculations were done on Excel to create a standard curve. According to the standard curve protein 
concentration, the volume for each sample  and XT sample buffer, 4X, Bio-Rad were calculated from the 
standard curve and then  added together.  
2.9 SDS-PAGE and Western Blots 
Samples were prepared by adding the ratio of sample buffer to protein according to the calculated ratio of 
the standard curve, into 1.5 ml tubes. Before proteins were added, it thawed slowly while kept on ice and 
were vortexed. After proteins were added, tubes were placed in a heating block at 95  C̊ for 5 min. Tubes 
were centrifuged for 1000 rpm for 2 min.    
Precast Mini-Protean TCX Gels (Bio-Rad, USA) (10 wells) was loaded with the Precision Plus ProteinTM Dual 
Xtra Prestained Protein ladder cat no 1610377 (Bio rad, USA). In each well 20 µg of sample was loaded. The 
running Buffer was 10x Tris-Glycine-SDS Buffer (Bio-Rad, USA). The SDS-PAGE was run on 200 Volt. The 
process was duplicated for two different antibodies. The gels were put on a Trans-Blot Turbo, Mini Format, 
0.2 µm PVDF membrane, Bio-Rad into a Trans Blot Turbo (Bio-Rad, USA) for 7 min.  
The membranes were washed in x10 TBS (with 1% Tween 80) for 5 min on a LABsmart shaker. It was then 
washed in 5% Milk powder (Diluted in TBS-Tween 80) for 1 hour on a LABsmart shaker. The membranes were 
placed in a 50 ml tube with the primary antibody, anti-mDectin-2α, Affinity Purified Goat IgG, cat no AF1525 
(R&D Systems, Minneapolis, USA) and reference primary antibody, GAPDH, mouse monoclonal IgG, Anti-
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Goat (Santa Cruz Biotechnology, Dallas, USA), with the ratio 1:1000 of Antibody to TBS-Tween 80 and was 
left overnight on a roller at 4  ̊C.  
The next day the membranes were washed 3 times in TBS-Tween 80 buffer. The membranes were added in 
a 50 ml tube with the secondary antibody, Donkey anti-Goat IgG-HP (Santa Cruz Biotechnology, Dallas, USA), 
with 1 µl of antibody in 5 ml of TBS-Tween 80.  
Chemiluminescence substrate (250 µl Clarity Max Western ECL Substrate enhancer solution (Bio-Rad, USA) 
and 250 µl Clarity Max Western ECL Substrate peroxide solution (Bio-Rad, USA)) was added on the section 
where the band was and after 10 seconds the band was visualised on the Gel-doc with Lab Image software, 
Bio-Rad.   
2.10 Estimating number of cells   
A test was done with THP1 Human macrophage cell line (ATCC TIB- 202) to conclude the number of cells 
added into each well of a 96 well plate (Cellstar, Sigma-Aldrich, USA) that will deliver an 80-90% confluency. 
THP1 cells were cultured in RPMI- 1640 (containing L-glutamine and Na-bicarbonate, Lonza) with FBS 
(Biochom, Germany) as growth medium and PMA (Phorbol 12 myristate 13-acetate 1µl per 1 ml of medium).  
In a paper by Robinson, M.J et al, the blocking of Dectin-2 receptor with anti Dectin-2 was done on BMDC 
(Bone marrow dendritic cells). In the study, 1 x 105 BMDC was cultured overnight in a 96 well plate.  
(Robinson et al., 2009).  
The calculation of this study was based on a concentration of 5 x 105 per 1 ml (for 1 x 105 cells in 96 well plate 
with which is about 200 µl a well). Different number of cells were experimented with to establish what would 
be the ideal number of cells to start with in order to deliver the best confluency.  
 
 
Stellenbosch University  https://scholar.sun.ac.za
21 
 
Table 2.1 Different THP1 cell number to observe the best confluency in a 96 well plate. PMA (Phorbol 12 
myristate 13-acetate) RPMI (Roswell Park Memorial Institute). 
Test Cell Number Volume of cells  Volume of PMA and RPMI 
medium 
Total volume per 
well  
1 20 000 40 µl 260 µl 300 µl 
2 40000 80 µl 220 µl 300 µl 
3 50 000 100 µl 200 µl 300 µl 
4 75 000 150 µl 150 µl 300 µl 
5 100000 200 µl 100 µl 300 µl 
 
After a week the confluency was observed under a microscope and it was found that beginning with 50 000 
cells had the best confluency. After a week, the cells increased 10-fold, generating 5 x 105 cells.  
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2.11 Blocking the Dectin-2 Receptor 
Six conditions were included in this experiment: 1) Uninfected BMDMs with anti-Dectin-2, 2) Uninfected 
BMDMs with an Isotype control, 3) Uninfected BMDMs with no antibody, 4) H37Rv infected BMDMs with 
anti-Dectin-2, 5) H37Rv infected BMDMs with an Isotype control and 6) H37Rv infected BMDMs with no 
antibody.  
In the paper by Robinson, M.J et al, a concentration of 10 µg per ml was used for anti-Dectin-2 and the 
isotype control when it was added to the BMDCs. The anti-Dectin-2 and isotype control was given 1-3 hours 
to bind to the receptors on the cell and kept on ice (4  ̊C). An Isotype control was included to insure that no 
non-specific binding occurred with the constant region of the IgG antibody. 
BMDMs were extracted and seeded as discussed earlier in 2.2. A concentration of 5 x 105 cells per ml was 
plated out in 96 well plates and incubated at 37  C̊, 5% CO2. After a week the cells where treated according 
to the six different conditions.  
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 1 2 3 4 5 6 7 8 
A UA UA UA  HA HA HA  
B         
C UI UI UI  HI HI HI  
D         
E UN UN UN  HN HN HN  
F         
 
The anti- Dectin 2 (anti-mDectin-2α, Affinity Purified Goat IgG, cat no AF1525 ,R&D Systems, Minneapolis) 
and the Isotype control (Normal Goat IgG control, cat no AB-108-C, R&D Systems, Minneapolis)  was added  
 
BMDMs were treated with a concentration of 10 µg per ml, along with RPMI-1640, supplemented with FBS 
and CSF. The plates were then left on ice for 2 hours.  
The plates were washed x 3 with RPMI-1640 medium. Three of the conditions BMDMs were infected with 
H37Rv in the same way as discussed in 2.3. Infection of BMDMs were only done with H37Rv because of the 
limited amount of the anti-Dectin-2 antibody. After 12h and 96h of infection, the supernatant was collected 
and syringed with 1ml syringe and filtered (Acrodisc LC 13 mm Syringe Filter with 0.2 µm PVDF Membrane, 
Life Sciences). The supernatant samples were stored at -80  ̊C . The experiment was done for three biological 
replicates and it also included  three technical replicates for each experiment.  
 
 
Figure 2.1 96 well plate layout of the six conditions 1) UA (Uninfected anti-Dectin 2, 2) UI (Uninfected 
Isotype control, 3) UN (Uninfected No antibody, 4) HA (H37Rv anti-Dectin, 5) HI (H37Rv Isotype), 6) HN 
(H37Rv No antibody).  
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2.11.1 Colony Forming Units  
After 12 and 96 hours respectively, the BMDMs infected with H37Rv, were washed three times with RPMI-
1640. To lyse the cells, 100 µl of 0.1 % Triton was added to each well that were infected with H37Rv. Serial 
dilutions were made (1 x10-1 – 1 x 10-4) with 7H9 medium and plated out on Middelbrook 7H11 medium 
supplemented with 10 % OADC. After 3 weeks CFU (Colony Forming Units) were counted and compared with 
the three different conditions: 1) BMDMs infected with H37Rv with Anti-Dectin-2, 2)BMDMs infected with 
H37Rv with Isotype control, 3)BMDMs infected with H37Rv with no antibody. The experiment was done for 
three biological replicates and it also included  three technical replicates for each experiment. The CFUs at 
12h and 96h were presented in a histogram graph with a ratio error bar,  where a one-way ANOVA (and 
Nonparametric) test was done, with a Bonferroni ( compare all pairs of columns) post-test. The significance 
level was Alpha = 0.05 (95%  confidence intervals). 
2.11.2 ELISA of TNFα and IL-10  
Enzyme-linked immunosorbent assay (ELISA) was performed for two cytokines that included TNF-α and IL-
10. ELISA was done with the Mouse TNF-α ELISA MAXTM Dulux Set (Cat no 430904, Biolegend, USA), and 
Mouse IL-10 ELISA MAXTM Duluxe Set (Cat no 431414, Biolegend, USA), according to manufacturer’s 
instructions. The supernatant was collected from the macrophages after infection of 12h and 96h according 
to manufacturer’s instructions. The experiment was done for three biological replicates for each experiment 
and 2 technical duplicates. The ELISA plates were read on a Versa Max microplate reader at a wavelength of 
450 nm and 750 nm.  
ELISA results were analysed in Excel and Graphpad Prism. The 570nm absorbance values were subtracted 
from the 450nm absorbance values before the blank absorbance values were subtracted from the standards 
and the sample values to get the true OD values. In Prism a standard curve was drawn with a nonlinear 
regression curve fit. The unknowns were interpolated from the standard curve (second order polynomial). 
From there the sample concentrations (pg per ml) were presented in a histogram graph with a ratio error 
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bar,  where a one-way ANOVA (and Nonparametric) test was done, with a Bonferroni ( compare all pairs of 
columns) post-test. The significance level was Alpha = 0.05 (95%  confidence intervals). 
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CHAPTER 3: Results 
3.1 Gene Expression  
3.1.1 The MOI (Multipicity of Infection)  
After 4h of infection for three biological replicates, the BMDMs were washed with RPMI. Triton (0.1%) was 
added to lyse the BMDMs and release the mycobacteria that were taken up. CFU counts were done to 
calculate the MOI for infection. The MOI was expected to stay consistent for the experiment to be 
reproducible. The MOI was calculated by the number of BMDMs (2x 106) divided by the number of 
mycobacteria that were taken up. The mean of the MOIs in all the conditions and biological replicates was 
determined to be about 1.446 and the SEM 0.0833.  
 
 
 
 
0
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1
1.2
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1.8
2
M.Tuberculosis 12h BCG 12h M.Smegmatis 12h
MOI (Multiplicity of Infection)
Infection 1 Infection 2 Infection 3
Figure 3.1 The MOI was taken at 4h for all infections. The strains and different biological replicates 
had an MOI close to 2 and MOI was fairly consistent in the different strains and biological replicates. 
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3.1.2 RNA Quality and Quantity 
The RNA samples were sent to the Central Analytical Facility (CAF) of Stellenbosch University to assess the 
quality and quantity of it. This is a summary of the results that were generated by the Agilent 2100 
Bioanalyzer. All qPCRs were done based on these values. It included the RNA concentration and RIN (RNA 
integrity number) values. All RNAs extracted at 12h exhibited an RIN value of 10, indicating the highest 
quality RNA possible. For the 96h timepoint, only 1 RNA sample had a lower RIN value of 7.2. The 
concentration of all RNA samples ranged from about 300 to 700 µg per µl for the 12h RNA samples. For the 
96h samples the RNA concentration ranged from about 100-300  µg per µl. Based on these results, I 
continued with cDNA synthesis, followed up with qPCR. 
Table 3.1 The RIN of RNA Extracted at 12h 
 
12 Hours RNA (ng per µl) 
Strain Infection 1 Infection 2 Infection 3 
 Concentration  RIN Concentration RIN Concentration RIN 
H37Rv 303 10 273 10 547 10 
M. bovis BCG 333 10 434 10 648 10 
M. smegmatis 298 10 393 10 543 10 
Uninfected 354 10 263 10 692 10 
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Table 3.2 The RIN of RNA extracted at 96h  
96 Hours RNA (µg per ml) 
Strain Infection 1 Infection 2 Infection 3 
 Concentration RIN Concentration RIN Concentration RIN 
H37Rv 276 10 223 10 259 7.2 
M. bovis BCG 267 10 233 10 211 10 
Uninfected 090 10 111 10 287 10 
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3.1.3 Gene Expression 
The qPCR results were analysed in GraphPad Prism software where statistical analysis was applied. A One-
way ANOVA (and Nonparametric) test was done, with a Bonferroni ( compare all pairs of columns) post-test. 
The significance level was Alpha = 0.05 (95%  confidence intervals). 
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Figure 3.2 Dectin-2 gene expression represented in a histogram after 12h and 96h of infection. At 12h 
after infection a significant upregulation has occurred in BMDMs infected with surviving mycobacteria 
compared to BMDMs infected with non-surviving mycobacteria. At 96h after infection Dectin-2 
expression decreased in all strains and no significant difference occurred between the different strains. 
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Figure 3.3 TNF α gene expression  represented in a histogram after 12h and 96h of infection. At 12h 
after infection with M.smegmatis a significantly upregulation occurred compared to infection with 
the other strains and uninfected. At 96h after infection the uninfected BMDMs had a significant 
upregulation compared to the infected BMDMs.   
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For the 12h time point the four conditions included: BMDMs that were uninfected, and infected with 
respectively M. smegmatis, M. bovis BCG and H37Rv. At the 96h time point, BMDMs infected with M. 
smegmatis was excluded since  M. smegmatis is killed inside the host macrophages after 24h and a problem 
with extracellular growth in RPMI-1640 medium was encountered.  
 
In figure 3.2, after 12h after infection upregulation occurred in BMDMs that were infected and uninfected. 
A significant upregulation did occur in BMDMs infected with surviving mycobacteria compared to BMDMs 
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Figure 3.4 IL 10 gene expression represented in a histogram after 12h and 96h of infection. At 12h after 
infection with BCG and M.smegmatis a significant upregulation occurred compared to infection with 
the uninfected BMDMs. At 96h upregulation occurred in all BMDMs including infected and uninfected.  
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infected with non-surviving mycobacteria. The three *** indicate a significant difference with P value (p ≤
0.0010), with a 0.1 % that this difference occurred due to chance. At 96h fold change decreased with BMDM 
infection except for the uninfected that increased, but no significant difference occurred.  
 
In figure 3.3 and 3.4, gene expression was done on cytokines that are known to be induced when the Dectin-
2 receptor recognize M.tuberculosis, which were the cytokines TNF α and IL 10 to obtain an overview of the 
cytokine release after 12h and 96h infection with different mycobacteria strains in BMDMs.  
 
In figure 3.3, expression of TNF α occurred in all BMDM conditions. After 12h of infection, BMDMs infected 
with M.smegmatis significantly upregulated TNF α compared with uninfected BMDMs and BMDMs that were 
infected with the other mycobacterium strains. After 96h of infection the uninfected BMDMs significantly 
upregulated TNF α compared to the infected BMDMs.  
 
In figure 3.4, expression of IL 10 occurred in all BMDM conditions. After 12h of infection there was a 
significant upregulation in BMDMs infected with M.smegmatis and BCG when compared to the uninfected 
BMDMs. The two ** indicate a significant difference with p value (p ≤ 0.01), with a 1 % that this difference 
occurred due to chance. One * indicate a significant difference with p value (p ≤ 0.05), with a 5 % that this 
difference occurred due to chance. After 96h of infection no significant difference occurred between the 
BMDM conditions. 
 
3.2 Protein Expression 
To assess whether the qPCR data on Clec4n correlates with an increase in the protein levels of Dectin-2, 
protein was extracted from BMDMs that have been infected with M. smegmatis, M. bovis BCG and H37Rv 
as well as uninfected BMDMs after 12h and 96h respectively, (excluding M. smegmatis for 96h) for western 
blot. The reference antibody, GAPDH was used (gapdh is a housekeeping gene) to determine whether the 
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protein extraction, and western blots have been done correctly to reliably quantify the level of Dectin-2. 
Unfortunately the inconsistency of the GAPDH protein expression between the different conditions and 
biological replicates occurred therefor no conclusions could be drawn from this data. The Full western blot 
is included in the appendix.  
 
 
 
 
 
 
 
 
 
3.3 Blocking the Dectin-2 receptor  
3.3.1 Survival of pathogenic mycobacteria  
Six conditions were included in this experiment: 1) Uninfected BMDMs with anti-Dectin-2, 2) Uninfected 
BMDMs with an Isotype control, 3) Uninfected BMDMs with no antibody, 4) H37Rv infected BMDMs with 
Figure 3.5 Western blot for Dectin-2 protein and GAPDH protein.  The numbers were labelled accordingly, 1) 
12 hours experiment 1 uninfected, 2) M. smegmatis , 3) BCG, 4) H37Rv, 5) experiment 2 uninfected, 6) M. 
smegmatis, 7) BCG, 8) H37Rv, 9) experiment 3 uninfected, 10) M. smegmatis, 11) BCG, 12) H37Rv, 13) 96 
hours experiment 1 uninfected, 14) BCG , 15) H37Rv, 16) experiment 2 uninfected, 17) BCG , 18) H37Rv, 19) 
experiment 3 uninfected, 20) BCG, 21) H37Rv.  
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anti-Dectin-2, 5) H37Rv infected BMDMs with an Isotype control and 6) H37Rv infected BMDMs with no 
antibody.  
The conditions that were infected with H37Rv, were plated out on 7H11 Middlebrook medium with OADC 
enrichment and incubated at 37  ̊C, after a 12h and 96h incubation. After 3-4 weeks incubation, the plates 
were counted for CFUs. As can be observed from Table 3.4 the treatment of the cells with Dectin-2 antibody 
decreased the amount of H37Rv at 12h post infection compared to the isotype antibody and no antibody  
controls. However, no differences in growth are observed in CFUs from 12h to 96h post infection. 
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Figure 3.6 represents the percentage uptake after 12h of Infection in BMDMs infected with H37Rv and 
treated with either the anti-Dectin-2 antibody, the isotype control or have no antibody treatment. There 
was found to be a significant decrease in the BMDMs treated with the anti-Dectin-2 antibody compared 
to BMDMs and no antibody treatment. 
Stellenbosch University  https://scholar.sun.ac.za
35 
 
.  
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CFU after 96h Infection
D
ec
tin
-2
Is
ot
yp
e 
C
on
tr
ol
N
o 
A
nt
ib
od
y
0
5000
10000
15000
*
C
F
U
CFU after 12h Infection
D
ec
tin
-2
Is
ot
yp
e 
C
on
tr
ol
N
o 
A
nt
ib
od
y
0
5000
10000
15000
***
***
*
C
F
U
Figure 3.7  CFU count and percentage uptake of pathogenic mycobacteria (H37Rv) was compared in 
BMDMs that were treated with a Dentin-2 antibody, Isotype control and no antibody after 12h and 
96h infection to determine if there is any change in CFUs between the conditions. 
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3.3.2 Cytokine release of TNF α and IL-10  
Supernatant was collected in all conditions after 12h and 96h infection. ELISAs were done to estimate the 
concentration (pg per ml) of TNF-α and IL-10.  
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Figure 3.8 TNF α production represented in a histogram after 12h and 96h infection with H37Rv in 
BMDMs. After 12h of infection, BMDMs infected with H37Rv and treated with anti-Dectin-2 
antibody significantly upregulated TNF α compared with BMDMs infected with H37Rv and no 
antibody treatment as well as uninfected BMDMs with anti-Dectin-2 antibody treatment. After 96h 
of infection, production of TNF α decreased in all conditions and no significant difference occurred. 
(A = Anti-Dectin-2 antibody, I = Isotype control, N= No antibody treatment)  
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In Figure 3.7, after 12h and 96h of Infection all BMDM conditions had TNF α production. At 12h after 
infection, BMDMs infected with H37Rv and treated with the anti-Dectin-2 antibody had a significant higher 
production of TNF α compared to BMDMs infected with H37Rv and no antibody treatment as well as 
compared to uninfected BMDMs treated with the anti-Dectin-2 antibody. The uninfected BMDMs that were 
treated with the anti-Dectin-2 antibody had a higher production of TNF α than the other uninfected 
conditions. After 96h of infection a decrease was observed in all conditions and no significant difference 
occurred between these conditions.    
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Figure 3.9 IL 10 production represented in a histogram after 12h and 96h of infection with H37Rv in 
BMDMs. After 12h of infection IL 10 production occurred in the BMDMs that were infected, but Il 10 
production in the uninfected BMDMs were lower than the limit of detection. No significant difference 
occurred between the infected BMDMs. After 96h of infection, IL-10 production was lower than the limit 
of detection. (A = Anti-Dectin-2 antibody, I = Isotype control, N= No antibody treatment) 
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In figure 3.8, after 12h of infection, only the infected BMDMs had a IL 10 release. After 96h of infection the 
IL 10 release was lower than the limit of detection.  
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CHAPTER 4: Discussion 
Although TB Drugs that are now found on the market have been able to cure many TB patients, multi-drug 
resistant and extremely drug resistant mycobacteria have become a threat for TB patients worldwide (WHO, 
2017).  An alternative way of combatting TB would be to increase the host immune response by host directed 
therapeutics rather than focussing only on developing drugs targeting the mycobacteria. As discussed 
previously pathogenic mycobacteria are able to avoid bactericidal host defences and have developed ways 
to prevent being eliminated by an active immune response (Eht and Schnappinger, 2009).  
 
In a high throughput RNA sequencing study, several genes of the host cells (BMDMs) were compared in 
expression and significance between mycobacteria (H37Rv and M. bovis BCG ) that are able to survive in the 
macrophage and mycobacteria (M. smegmatis) that are not. It was found that the expression of one of the 
genes, Clec4n was significantly higher in the BMDMs that were infected with the H37Rv and M. bovis BCG 
when compared to M. smegmatis and the uninfected macrophages. It is possible that Clec4n (Dectin-2) plays 
a role in the survival of pathogenic mycobacteria. 
4.1 Gene Expression  
4.1.1 The MOI (Multiplicity of Infection) 
The aim was to achieve a MOI of 2. The MOI was expected to stay consistent for the experiments to be 
reproducible. MOI was calculated by the number of BMDMs (2 x 106) infected, divided by the number of 
mycobacteria that were taken up by the cells.  
As mentioned in the methods, M. smegmatis was excluded at 96h time point of Infection. M. smegmatis was 
killed after 24h of infection in the macrophages (Kuehnel et al., 2001). M.smegmatis is a fast-growing 
mycobacteria that starts to grow extracellularly in the RPMI-medium and acts as contamination to the 
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BMDMs. Infection with M. smegmatis was excluded for qPCR and western blot experiments at a 96 h 
timepoint in this study. 
In figure 3.1, with calculations to obtain a MOI of 2, the MOIs did not reach 2, but were close to 2 and fairly 
consistent between different conditions and biological replicates. Possible reasons for that fact that the 
observed MOI that was not equal to 2 could be because the mycobacteria was not grown in Tween-80. 
Tween-80 prevents clumping of mycobacteria (Sani et al., 2010), which means without Tween-80, even with 
the SSF, this could possibly still be a factor that influences the uptake of mycobacteria by BMDMs. It was also 
found that even after counting the cells with a haemocytometer, calculating the volume that needed to be 
added to each well and mixing before adding the volume, still resulted in a difference in the confluency 
between wells when observed under the microscope.  
4.1.2 RNA Quality and Quantity 
The RNA concentration (µg per ml) at 12h in table 3.1 and 96h in table 3.2 was high enough to convert to 
cDNA and use for qPCR. The RIN (RNA Integrity Number) was calculated by the ratio area under 18S and 28S 
RNA peaks to the total area under the graph of an electropherogram. The RIN value is an indication of the 
amount of RNA that has been degraded (Schoeder et al., 2006). When the RIN value is 10, all the RNA is still 
intact. It was found that the RNA after 12h infection (table 3.2) and 96h infection (table 3.3), all had RIN 
values of ten, expect for the BMDMs that were infected with H37Rv after 96h of infection which had a RIN 
value of 7.2. This can be due to the conditions of the cells, growth of infection may have caused stress of the 
cells, the way samples were handled and sample measurement. The high difference in RNA concentration 
between the 12h and 96h time point could maybe be due to the BMDMs that were washed more times at 
96h, which could lead to some of the BMDMs getting lost during washing. 
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4.1.3 Gene Expression 
4.1.3.1 Clec4n gene expression  
Gene expression of Dectin-2 at a 12h and 96h timepoint of infection with M.smegmatis, BCG and H37Rv in 
BMDMs is presented in figure 3.2. After 12h of infection, BMDMs that were infected with BCG and H37Rv 
significantly upregulated Dectin-2, compared to BMDMs infected with M.smegmatis as well as uninfected 
BMDMs. These results validate the results that were found in the RNA sequencing data. Because H37Rv and 
BCG is able to survive in the macrophage (Meena and Rajni, 2010) and M.smegmatis dies after 24h (Kuehnel 
et al., 2001), these results can suggest that the Dectin-2 receptor may influence the survival of H37Rv and 
BCG. It is still unknown in the literature whether Dectin-2 has an influence on the survival of mycobacteria, 
however it was found in Dectin-1 deficient mice that there was a reduction in pulmonary bacilli loads but no 
significant changes in pulmonary pathology, cytokine levels or the ability of mice to survive infection with 
M.tuberculosis (Marakalala et al., 2011). After 96h a decrease occurred in the infected BMDMs. This can 
indicate that Dectin-2 plays a more important role at the early stages of infection. It is possible that after 96h 
of infection, other receptors that M.tuberculosis will bind to in a higher abundancy were higher expressed 
and that less stimulation through M.tuberculosis to the Dectin-2 receptor led to a decrease in Dectin-2 
expression.  At 96h the expression of Dectin-2 in BMDMs with non-surviving mycobacteria could not be 
determined since M.smegmatis was killed after 24h of infection in the macrophages. This made it difficult 
to compare non-surviving mycobacteria to surviving mycobacteria and determine the influence of Dectin-2 
at 96h after infection. Eliminating the Clec4n gene or the Dectin-2 receptor will give more insight in whether 
this gene plays a role in the survival of these strains.  
4.1.3.2 Cytokine Gene Expression of TNF α 
After binding of ManLaM to the Dectin-2 (Clec4n) receptor on DCs or Macrophages, Dectin-2 induces the 
production of pro- and anti-inflammatory cytokines, that include TNF α and IL-10 (Marakalala and Ndlovu, 
2017).  The gene expression of TNFα and IL-10 was observed to obtain an overview of the cytokines TNF α 
and IL 10 expression in BMDMs after 12h and 96h infection with different mycobacteria strains in BMDMs.    
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In figure 3.3, the TNF α gene was found to be upregulated in each of the conditions, however after 12h of 
infection,  TNF α expression was significantly upregulated in BMDMs infected with  M.smegmatis compared 
to uninfected BMDMs and BCG infected BMDMs. This high expression in BMDMs infected with M.smegmatis 
is to be expected since M.smegmatis is not able to survive in the macrophage. A high TNF α  likely contributes 
to the killing of M.smegmatis. 
After 96h of infection, uninfected BMDMs had a high increase of TNF α compared to the 12h infection and a 
significant higher expression of TNF α compared to both the infected BMDMs. This result was not expected,  
in the ELISA assays the uninfected with no antibody treatment had a higher cytokine response than the 
infected BMDMs with no antibody treatment. The observation of the cytokine release is a better 
representation of the cells immune response in comparison with gene expression. Gene expression does not 
always correlate with protein expression. Post translational modification may lead to a different protein 
expression as would be expected when compared to the gene expression. 
4.1.3.3 Cytokine Gene Expression of IL 10 
In figure 3.4, the IL 10 was found to be upregulated in all the BMDM conditions after 12h and 96h of infection. 
After 12h of infection, BMDMs infected with BCG and M.smegmatis were significantly upregulated 
compared to the uninfected BMDMs. After 96h of infection no significant difference occurred.  
Based on the results, the TNF-α and IL-10 gene was not relatively expressed in the same way as the Clec4n 
gene between the different conditions. This means that Clec4n expression does not have a direct effect on 
the expression of TNFα and IL-10.  
 
4.2 Protein Expression 
In figure 3.5, the GAPDH gene (which is a housekeeping gene)  was found to be present on the blot in each 
of the samples but the concentrations were not consistent. The optimising of western blots included: 
different transmembrane blotting time, different blocking time, different concentrations of primary and 
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secondary antibodies, and repeating protein extraction. Low concentrations of protein could have led to 
inconsistency. 
The Dectin-2 protein were found to be expressed in some of the samples, such as the uninfected BMDMs, 
but some samples did not show any bands. Anti-mDectin-2α, Affinity Purified Goat IgG, is a polyclonal 
antibody and it could be possible that more non-specific binding took place that led to faint or no bands. No 
inferences or conclusions can be drawn from this data. 
 
4.3 Blocking the Dectin-2 receptor  
To achieve a better understanding in the role that Dectin-2 plays during infection of pathogenic mycobacteria 
in mouse macrophages, the Dectin-2 receptor was blocked with an anti-Dectin-2 Antibody, to observe the 
effects on mycobacterial survival and percentage uptake. 
 
4.3.1 Difference in survival of pathogenic mycobacteria 
After 12h of infection the percentage uptake was observed. In figure 3.6, there was a significant decrease in 
the uptake of H37Rv in BMDMs  treated with the anti-Dectin-2 antibody compared to the BMDMs with no 
antibody treatment. A change in percentage uptake also occurred between BMDMs with anti-Dectin-2 
antibody treatment and BMDMs with the isotype treatment.  
 
In figure 3.7, after 12h of infection there was a significant decrease in the CFU in the BMDMs treated with 
anti-Dectin-2 antibody compared to CFUs in BMDMs with isotype control treatment and no antibody 
treatment. After 96h the significant decrease of CFUs in BMDMs treated with the anti-Dectin-2 antibody 
compared to the CFUs in BMDMs with no antibody treatment was maintained. When the CFUs of 12h of 
infection was compared to the CFUs of 96h there was no change in the survival or growth of the 
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mycobacteria. The results can indicate that Dectin-2 may influence the percentage uptake of H37Rv but not 
the survival.  
 4.3.2 Cytokine release of TNFα and IL-10  
ELISA was performed on supernatants collected after a 12h and 96h post-infection, with the following six 
conditions: 1) Uninfected BMDMs with anti-Dectin 2, 2) Uninfected BMDMs with an Isotype control, 3) 
Uninfected BMDMs with no antibody, 4) H37Rv infected BMDMs with anti-Dectin 2, 5) H37Rv infected 
BMDMs with an Isotype control and 6) H37Rv infected BMDMs with no antibody. The concentration (pg per 
ml) of TNFα and IL-10 was calculated with a standard curve. Conditions that only had one variable were 
compared with each other.  
In figure 3.8, in both timepoints ,TNF α release occurred in all the different conditions. The BMDMs that were 
infected with pathogenic mycobacteria (H37Rv) after 12h time point of infection, all had a higher 
concentration (pg per ml) compared to the BMDMs that were uninfected, as expected. There was a 
significant increase of TNF α at the 12h time point of infection between the BMDMs infected with H37Rv and 
treated with the anti-Dectin-2 antibody, and between the BMDMs that were infected with H37Rv and not 
treated with the antibody. This increase can be because blocking the Dectin-2 receptor causes the increase 
of  mycobacteria binding to other receptors that also leads to a high TNF α release. A higher release of TNF 
α can lead to killing pathogenic mycobacteria. Uninfected BMDMs had a higher production of TNF α release 
than the uninfected BMDMs treated with the isotype control and no antibody treatment. It can be concluded 
that binding of the antibody stimulated the Dectin-2 receptor, that leads to a higher production of TNF-α. 
At the 96h time point after infection, the production of TNF-α had decreased in all the BMDMs conditions. 
No significant difference in production was found between conditions at this time point.  
In figure 3.9, at the 12h time point of infection, only the BMDMs that were infected with mycobacteria 
(H37Rv) had an increased in the release of the IL-10 but no significant difference occurred between these 
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conditions. In the uninfected BMDMs at 12h post-infection al IL-10 concentrations were below the limit of 
detection. 
At 96h all of the IL-10 concentrations (pg per ml) were found to be below the limit of detection on the 
standard curve. It can be concluded that blocking the Dectin-2 receptor does not have a significant effect on 
the IL-10 release during pathogenic mycobacteria post-infection at 12h or 96h of infection respectively. It 
can be concluded from the 96h post-infection that IL10 does not play a role at the later (96h) stages of 
infection.  
4.4 Future studies 
To improve this study and to make it more reliable, experiments such as  immunohistochemistry can be done 
to show that the anti-Dectin-2 Antibody binds to the surface of the BMDMs and not to mutant BMDMs 
deficient in Dectin-2.  This was a drawback in this study, since it could not be proven that the antibody was 
bound to the Dectin2 receptor. The only way to have some estimate whether the anti-Dectin-2 antibody did 
bind to the Dectin-2 receptor would be to observe the difference between the conditions of BMDMs that 
were treated with anti-Dectin2, Isotype control (non-specific binding) and no treatment.  
Gene silencing on the Clec4n gene (Dectin2 ) would be a much more sensitive assay. It would eliminate any 
Dectin-2 receptor and likely have a more robust estimation of the role of Dectin-2 production and activity. It 
is also possible that the binding of the Dectin-2 antibody can stimulate the receptor. Silencing would 
eliminate this unwanted side effect. 
To broaden the study, including more strains such as M. smegmatis and M. bovis BCG could  be done. Doing 
so, could make it possible to observe the effect that Dectin-2 has on non-pathogenic strains. It would be 
advisable to do ELISAs on more cytokines that Dectin-2 is known to effect during mycobacteria infection.  
Further, the effects observed in mouse bone marrow-derived macrophages may differ from what would be 
observed with human blood monocyte-derived macrophages and the human THP-1 cell line. The study 
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using the anti-Dectin-2 antibody must be repeated with human macrophages to obtain a better insight 
based on tuberculosis in humans. 
4.5 Conclusion 
According to the qPCR results Clec4n is significantly upregulated, which indicates a possible role in BMDMs 
of M. bovis BCG and H37Rv compared to uninfected and M. smegmatis.  
When the CFUs of 12h of infection was compared to the CFUs of 96h there was not a change in the survival 
or growth of the mycobacteria. Its results can indicate that Dectin-2 may influence the percentage uptake of 
H37Rv but not the survival.  
 
In the ELISA results it was found that there was a significant increase in the release of the TNF α cytokine, in 
the infected BMDMs treated with the anti-dectin-2 antibody compared to the infected BMDMs  with no 
antibody treatment from which can be concluded that blocking the Dectin-2 receptor causes the increase of  
mycobacteria binding to other receptors that also lead to a high TNF α release. A higher release of TNF α can 
lead to killing pathogenic mycobacteria. There was found to be a higher production in TNF α with BMDMs 
that were not infected with H37Rv but treated with Dectin-2 antibody in comparison with BMDMs with no 
infection and Isotype control and no antibody treatment. This is found to be an experimental flaw as it would 
have been expected to have the same amount of TNF-α production in each of these three variables.  
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CDNA Optimisation 12h 22-01-2018 
 RNA Concentration (ng per µl) 
1 Uninfected-12-1 432 
2 Uninfected-12-2 305 
3 Uninfected-12-3 353  
4 M.Smegmatis-12-1 298 
5 M.Smegmatis-12-2 393 
6 M.Smegmatis-12-3 543 
7 BCG-12-1 333 
8 BCG-12-2 434 
9 BCG-12-3 648 
10 H37RV-12-1 303 
11 H37RV-12-2 273 
12 H37RV-12-3 547 
13 R179-12-1 387 
14 R179-12-2 299 
15 R179-12-3 319 
 
 RNA volume (0.5 ng per µl) (µl) 
 Sample RNA GDNA H2O MM Total 
1 Uninfected-12-1 1.2 2 10.8 6 20 
2 Uninfected-12-2 1.6 2 10.4 6 20 
3 Uninfected-12-3 1.4 2 11.6 6 20 
4 M.Smegmatis-12-1 1.7 2 10.3 6 20 
5 M.Smegmatis-12-2 1.3 2 10.7 6 20 
6 M.Smegmatis-12-3 0.9 2 11.1 6 20 
7 BCG-12-1 1.5 2 10.5 6 20 
8 BCG-12-2 1.2 2 10.8 6 20 
9 BCG-12-3 0.8 2 11.2 6 20 
10 H37RV-12-1 1.7 2 10.3 6 20 
11 H37RV-12-2 1.8 2 10.2 6 20 
12 H37RV-12-3 0.9 2 11.1 6 20 
13 R179-12-1 1.3 2 10.7 6 20 
14 R179-12-2 2.2 2 09.8 6 20 
15 R179-12-3 1.6 2 10.4 6 20 
16 NTC 0.0 2 12 6 20 
 
 X1 X 17 
RT Enzyme 1 µl 17 μl 
RT Buffer 4 µl 68 μl 
RT Primer mix 1 µl                          17 μl                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
 
Dilutions: 80 µl of RNase Free Water and 20 µl of cDNA .Calibrator: 10 µl of each sample  
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CDNA Optimisation 96h 24-01-2018 
 RNA Concentration (ng per µl) 
1 BCG-96-1 267 
2 BCG-96-2 233 
3 BCG-96-3 211 
4 H37RV-96-1 276 
5 H37RV-96-2 223 
6 H37RV-96-3 259 
7 R179-96-1 196 
8 R179-96-2 182 
9 R179-96-3 194 
10 Uninfected-96-1 90 
11 Uninfected-96-2 111 
12 Uninfected-96-3 287 
 
 RNA volume (0.5 ng per µl) (µl) 
 Sample RNA GDNA H2O MM Total 
1 BCG-96-1 1.9 2 10.1 6 20 
2 BCG-96-2 2.2 2 09.8 6 20 
3 BCG-96-3 2.4 2 09.6 6 20 
4 H37RV-96-1 1.8 2 10.2 6 20 
5 H37RV-96-2 2.2 2 09.8 6 20 
6 H37RV-96-3 1.9 2 10.1 6 20 
7 R179-96-1 2.6 2 09.4 6 20 
8 R179-96-2 2.8 2 09.2 6 20 
9 R179-96-3 2.6 2 09.4 6 20 
10 Uninfected-96-1 5.6 2 06.4 6 20 
11 Uninfected-96-2 4.5 2 06.6 6 20 
12 Uninfected-96-3 1.7 2 10.3 6 20 
13 Non-Transcription 0.0 2 12.0 6 20 
14 Non-Transcription 0.0 2 12.0 6 20 
 
 X1 X 15 
RT Enzyme 1 µl 15 µl 
RT Buffer 4 µl 60 µl 
RT Primer mix 1 µl 15 µl                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
 
Dilutions: 80 µl of RNase Free Water and 20 µl of cDNA 
Calibrator: 10 µl of each sample  
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Dectin-2 Western Blot  
 
 
 
 
 
 
 
 
27 
kDa 
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GAPDH Western Blot  
 
37 KDa  
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